लोड हो रहा है...

Recent Advances in the Design and Development of Novel Negative Allosteric Modulators of mGlu(5)

[Image: see text] Negative allosteric modulators (NAMs) of metabotropic glutamate receptor subtype 5 (mGlu(5)) have remained attractive to researchers as potential therapies for a number of central nervous system related diseases, including anxiety, pain, gastresophageal reflux disease (GERD), addic...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखक: Emmitte, Kyle A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Chemical Society 2011
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172159/
https://ncbi.nlm.nih.gov/pubmed/21927649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn2000266
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!